Trial · NCT04345848

Preventing COVID-19 Complications With Low- and High-dose Anticoagulation

NCT04345848, Phase 3, Terminated, University Hospital, Geneva

3 sourcestrials-2026-11-12-0.5.0

Cite this record

ConductScience Library. Preventing COVID-19 Complications With Low- and High-dose Anticoagulation. Trials, record NCT04345848. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04345848

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title: Preventing COVID-19 Complications With Low- and High-dose Anticoagulation
NCT number: NCT04345848
Status: Terminated
Phases: Phase 3
Enrollment: 160 participants, actual
Lead sponsor: University Hospital, Geneva
Conditions: COVID, Sars-CoV2
Interventions: Enoxaparin
First posted: 2020-04-15
Last updated: 2021-09-14

Source ClinicalTrials.gov

Registered outcomes14

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

List	Outcome	Time frame	Description
Primary	Composite outcome of arterial or venous thrombosis, disseminated intravascular coagulation and all-cause mortality	30 days	Risk of arterial or venous thrombosis, disseminated intravascular coagulation and all-cause mortality
Secondary	Arterial thrombosis	30 days	Risk of ischemic stroke, myocardial infarction and/or limb ischemia
Secondary	Venous thromboembolism	30 days	Risk of symptomatic venous thromboembolism or asymptomatic proximal leg deep vein thrombosis
Secondary	Disseminated intravascular coagulation	30 days	Risk of DIC
Secondary	All-cause mortality	30 days	Risk of all-cause mortality
Secondary	Sepsis-induced coagulopathy	30 days	Risk of SIC
Secondary	Acute respiratory distress syndrome	30 days	Risk of ARDS
Secondary	Durations of hospital stay, ICU stay, ventilation	30 days	Number of days with these care processes
Secondary	Sequential organ failure assessment score	30 days	Highest score per participant
Secondary	Clinical deterioration	30 days	Risk of clinical deterioration

1 to 10 of 14Source ClinicalTrials.gov

See all 14 registered outcomes

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers3

The papers the trial lists on ClinicalTrials.gov.

PMID	Listed as	Source
32407672	DERIVED	PubMed
33502773	DERIVED	PubMed
35244208	DERIVED	PubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov: 2026-11-12; ClinicalTrials.gov
Results, from AACT: 2026-03-23; AACT
NIH grant links: 2026-11-13; NIH RePORTER

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT04345848

GET https://conductscience.org/api/trials/v1/NCT04345848/registered

API reference For AI assistants